A Phase 1b study to evaluate HMBD-001 with or without chemotherapy in participants with advanced solid tumors harboring NRG1 gene fusions or selected HER3 mutations

Project: Research

Project Details

StatusActive
Effective start/end date23/08/23 → 22/08/25

Keywords

  • Clinical trial
  • HMBD-001-102